SCHEMBL1044595

SCHEMBL1044595

CCCCCCCCCCCCCC(=O)ON(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.57
DNM1 Q05193 1/20 0.56
KDM6B O15054 1/20 0.54
KDM5C P41229 1/20 0.54
EGLN1 Q9GZT9 1/20 0.54
PHF8 Q9UPP1 1/20 0.54
KDM2A Q9Y2K7 1/20 0.54
LMNA P02545 2/20 0.53
PAM P19021 2/20 0.52
CES2 O00748 3/20 0.50
CES1 P23141 3/20 0.50
MAPT P10636 2/20 0.50
MAPK1 P28482 1/20 0.50
TSHR P16473 4/20 0.48
PPARG P37231 4/20 0.48
PPARD Q03181 4/20 0.48
PPARA Q07869 4/20 0.48
GPR84 Q9NQS5 3/20 0.48
HDAC11 Q96DB2 3/20 0.48
ALDH1A1 P00352 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5559122 1.00 DGKA (0.57) DGKADNM1KDM6BKDM5CEGLN1
SCHEMBL555756 1.00 DGKA (0.57) DGKADNM1KDM6BKDM5CEGLN1
SCHEMBL15436584 1.00 DGKA (0.57) DGKADNM1KDM6BKDM5CEGLN1
SCHEMBL10788076 1.00 DGKA (0.57) DGKADNM1KDM6BKDM5CEGLN1
SCHEMBL21603062 1.00 DGKA (0.57) DGKADNM1KDM6BKDM5CEGLN1
SCHEMBL6239209 1.00 DGKA (0.57) DGKADNM1KDM6BKDM5CEGLN1
SCHEMBL1671499 1.00 DGKA (0.57) DGKADNM1KDM6BKDM5CEGLN1
SCHEMBL1671758 1.00 DGKA (0.57) DGKADNM1KDM6BKDM5CEGLN1
SCHEMBL1671856 1.00 DGKA (0.57) DGKADNM1KDM6BKDM5CEGLN1
SCHEMBL28052374 0.98 DGKA (0.55) DGKADNM1KDM6BKDM5CEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9155914-B2 Composition for external application to skin KAO CORPORATION (JP) 2015-10-13 US claimed
US-20100273875-A1 Composition for External Application to Skin KAO CORPORATION (JP) 2010-10-28 US claimed
EP-2221040-A1 COMPOSITION FOR EXTERNAL APPLICATION TO SKIN Kao Corporation (JP) 2010-08-25 EP claimed
EP-1494637-A2 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 2005-01-12 EP claimed
WO-2003086331-A2 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 2003-10-23 WO claimed
US-20030199584-A1 Reduction of hair growth GILLETTE COMPANY, THE 2003-10-23 US claimed
EP-1014809-B1 AQUEOUS PRESERVATIVE AGENTS NORSK HYDRO AS (NO) 2001-11-28 EP claimed
EP-1014809-A1 AQUEOUS PRESERVATIVE AGENTS NORSK HYDRO ASA (NO) 2000-07-05 EP claimed
WO-1999012435-A1 AQUEOUS PRESERVATIVE AGENTS NORSK HYDRO ASA (NO) 1999-03-18 WO claimed
EP-4491929-B1 COATING LIQUID, PRODUCTION METHOD FOR COATING FILM, AND COATING FILM RESONAC CORP (JP) 2026-04-22 EP disclosed
EP-4726101-A1 WATER REPELLENT COMPOSITION AND METHOD FOR PRODUCING SAME Daikin Industries, Ltd. (JP) 2026-04-15 EP disclosed
US-20260098377-A1 FIBER STRUCTURE DAIKIN INDUSTRIES, LTD. (JP) 2026-04-09 US disclosed
EP-4707338-A1 COMPOSITION Daikin Industries, Ltd. (JP) 2026-03-11 EP disclosed
US-20260055554-A1 PULP COMPOSITION DAIKIN INDUSTRIES, LTD. (JP) 2026-02-26 US disclosed
CN-1131900-A Polyester-packaged hinokitiol-containing composition OTSUKA PHARMA CO LTD (JP) 1996-09-25 CN disclosed
WO-1995009590-A1 ABSORPTION ENHANCERS FOR TOPICAL PHARMACEUTICAL FORMULATIONS ODONTEX, INC. (US) 1995-04-13 WO disclosed
CN-1062081-A The hair growth regulating composition that contains epithelium cell supernatant-derived somatomedin PROCTER & GAMBLE (US) 1992-06-24 CN disclosed
US-4716208-A OLEOPHOBIC, HYDROPHOBIC TEXTILE FIBER FINISHES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1987-12-29 US disclosed
EP-0124236-B1 FLUORINE-CONTAINING COPOLYMERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1987-07-15 EP disclosed
EP-0124236-A1 Fluorine-containing copolymers E.I. DU PONT DE NEMOURS AND COMPANY (US) 1984-11-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260055554-A1 PULP COMPOSITION ADAR, DPM1, CD68 DGKA 916/4885DNM1 4652/4885KDM6B 3829/4885
US-20100273875-A1 Composition for External Application to Skin CUTA, COL14A1, COL2A1 DGKA 1879/4885DNM1 3572/4885KDM6B 1256/4885
US-20260098377-A1 FIBER STRUCTURE SMC2, SMCHD1, SMC4 DGKA 2852/4885DNM1 4717/4885KDM6B 664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.